{"id":"https://openalex.org/W2283728403","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7143","title":"Apoptotic effects of the docetaxel\u2192OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells","display_name":"Apoptotic effects of the docetaxel\u2192OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2283728403","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7143","mag":"2283728403"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.7143","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7143","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7143","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002620609","display_name":"Tatsuo Kimura","orcid":"https://orcid.org/0000-0002-5816-7132","observed_orcids":["https://orcid.org/0000-0002-5816-7132"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Kimura","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112046456","display_name":"Caroline Mahaffey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. M. Mahaffey","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088369097","display_name":"B. J. Pryde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. J. Pryde","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010265482","display_name":"Philip C. Mack","orcid":"https://orcid.org/0000-0003-4750-3812","observed_orcids":["https://orcid.org/0000-0003-4750-3812"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. C. Mack","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110112302","display_name":"Angela M. Davies","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. M. Davies","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036091074","display_name":"David R. Gandara","orcid":"https://orcid.org/0000-0003-1784-048X","observed_orcids":["https://orcid.org/0000-0003-1784-048X"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. R. Gandara","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021148471","display_name":"Paul H. Gumerlock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. H. Gumerlock","raw_affiliation_strings":["UC Davis Cancer Center, Sacramento, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Cancer Center, Sacramento, CA","institution_ids":["https://openalex.org/I4390039352"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4390039352"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"7143","last_page":"7143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9919999837875366},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.847000002861023},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7450000047683716},{"id":"https://openalex.org/keywords/drug-sequence","display_name":"drug sequence","score":0.453000009059906},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9100000262260437},{"id":"https://openalex.org/keywords/parp-cleavage","display_name":"PARP cleavage","score":0.7149999737739563},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9959999918937683},{"id":"https://openalex.org/keywords/p53-null-cells","display_name":"p53-null cells","score":0.9480000138282776},{"id":"https://openalex.org/keywords/calu-1-cells","display_name":"Calu-1 cells","score":0.8270000219345093},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5720000267028809},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7139999866485596},{"id":"https://openalex.org/keywords/akt-pathway","display_name":"AKT pathway","score":0.9739999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6186622977256775},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5781981945037842},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5260657668113708},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.46539413928985596},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4520227909088135},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.4405538737773895},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4187115430831909},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4169561564922333},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4063642621040344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31651678681373596},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3161008059978485},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21306616067886353},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.12068814039230347},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.11644551157951355},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.7143","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7143","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7143","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.7143","doi":"https://doi.org/10.1200/jco.2004.22.90140.7143","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.7143","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2052117064","https://openalex.org/W1998327095","https://openalex.org/W2067810310","https://openalex.org/W1544152155","https://openalex.org/W1911865937","https://openalex.org/W2034685364","https://openalex.org/W1637035453","https://openalex.org/W2422532154","https://openalex.org/W2150373927","https://openalex.org/W1976466737"],"abstract_inverted_index":{"7143":[0],"Background:":[1],"The":[2,111,174,248],"epidermal":[3],"growth":[4],"factor":[5],"receptor":[6],"(EGFR)":[7],"has":[8,29],"been":[9,30],"shown":[10,31],"to":[11,32,82,225,263],"signal":[12],"through":[13],"both":[14],"the":[15,68,75,83,129,181,185,189,204,215,228,234,253,291],"mitogen-activated":[16],"protein":[17,21],"kinase":[18,22,44],"(MAPK)":[19],"and":[20,126,163,199,208,222,240],"B":[23],"(AKT)":[24],"pathways,":[25],"each":[26],"of":[27,70,78,86,131,141,206,217,250,256,285,302],"which":[28],"be":[33],"abnormally":[34],"activated":[35],"in":[36,49,60,66,74,103,149,180,203,214,258,272,279],"NSCLC.":[37,61],"OSI-774":[38,142,307],"(Tarceva)":[39],"is":[40,57,96,123],"an":[41,54,97,243,294],"EGFR":[42,124,304],"tyrosine":[43],"inhibitor":[45],"with":[46,138,188,209,282,306],"anti-cancer":[47],"activity":[48],"clinical":[50],"trials.":[51],"Docetaxel":[52],"(Txt),":[53],"antimicrotubule":[55],"agent,":[56],"used":[58,117],"extensively":[59],"We":[62],"previously":[63],"reported":[64],"that":[65,94,100,261],"vitro":[67],"sequence":[69,85,191,205,216,249],"Txt":[71,145],"\u2192OSI-774":[72],"resulted":[73],"greatest":[76,175,254],"proportion":[77],"sub-G1":[79,238],"cells":[80,186,260],"compared":[81],"alternate":[84,108],"OSI-774\u2192Txt":[87],"(Gumerlock,":[88],"ASCO":[89],"2003).":[90],"Here":[91],"we":[92],"hypothesized":[93],"this":[95],"apoptotic":[98,244],"response":[99],"persists,":[101],"resulting":[102],"long-term":[104],"differences":[105],"from":[106],"these":[107,150],"administrations.":[109],"Methods:":[110],"NSCLC":[112,133,259],"cell":[113,176],"line":[114],"Calu1":[115],"was":[116,178],"as":[118],"a":[119,276],"model":[120],"because":[121],"it":[122],"positive":[125],"p53-null":[127,273],"like":[128],"majority":[130],"advanced":[132],"tumors.":[134],"Cells":[135],"were":[136,168,201],"treated":[137,187],"single":[139],"doses":[140],"(1\u03bcM,":[143],"24hrs),":[144],"(50nM,":[146],"18hrs),":[147],"or":[148,156,318,321],"sequences:":[151],"OSI-774\u2192Txt\u2192drug-free":[152],"media":[153],"for":[154,293],"72hrs":[155,195,226,266],"Txt\u2192OSI-774\u2192drug-free":[157],"media.":[158],"Cleaved":[159,197],"poly-ADP-ribose":[160],"polymerase":[161],"(PARP)":[162],"Caspase-3":[164,200,223],"apoptosis":[165,257],"marker":[166],"proteins":[167],"assessed":[169],"by":[170,194],"Western":[171],"blotting.":[172],"Results:":[173],"death":[177],"observed":[179],"Txt\u2192OSI-774\u2192media":[182],"sequence,":[183],"while":[184],"OSI-774\u2192Txt\u2192media":[190],"resumed":[192],"proliferation":[193],"post-treatment.":[196,267],"PARP":[198,221],"detected":[202],"Txt\u2192OSI-774,":[207],"simultaneous":[210],"treatment,":[211],"but":[212],"not":[213],"OSI-774\u2192Txt.":[218],"Further,":[219],"cleaved":[220],"persisted":[224,262],"after":[227],"Txt\u2192OSI-774":[229,251],"treatment.":[230],"These":[231,288],"data":[232,289],"support":[233],"previous":[235],"results":[236],"on":[237],"cells,":[239,274],"molecularly":[241],"demonstrate":[242],"response.":[245],"Conclusions:":[246],"1)":[247],"showed":[252],"levels":[255],"at":[264],"least":[265],"2)":[268],"This":[269],"effect":[270],"ocurred":[271],"suggesting":[275],"potential":[277],"role":[278],"tumor":[280],"types":[281],"high":[283],"frequencies":[284],"disrupted":[286],"p53.":[287],"form":[290],"basis":[292],"ongoing":[295],"phase":[296],"I":[297],"trial":[298],"examining":[299],"two":[300],"regimens":[301],"intermittent":[303],"blockade":[305],"plus":[308],"Txt.":[309],"(CM17101,":[310],"CA62505,":[311],"HHMI,":[312],"Aventis,":[313],"Genentech)":[314],"Author":[315],"Disclosure":[316],"Employment":[317],"Leadership":[319],"Consultant":[320],"Advisory":[322],"Stock":[323],"Ownership":[324],"Honoraria":[325],"Research":[326],"Funding":[327],"Expert":[328],"Testimony":[329],"Other":[330],"Remuneration":[331],"Aventis":[332,334],"Oncology":[333]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}